Hormone Therapy Shows Mood Benefits in Menopause Study

A retrospective study found that women who started systemic hormone therapy during menopause reported significant improvements in mood symptoms like depression, irritability, and anxiety, with the largest gains among those with severe baseline symptoms. The proportion of patients with severe mood symptoms fell from 62.3% to 24.6% after a mean follow-up of 4.5 months. Sleep scores also improved, suggesting hormone therapy may benefit psychological well-being beyond traditional menopause complaints.

The retrospective design means the findings show association rather than causation, and the absence of a control group limits direct attribution of mood gains to the therapy itself. Still, the magnitude of change among women with severe baseline symptoms—a mean improvement of nearly four points on the Menopause Rating Scale—suggests a clinically meaningful signal worth prospective investigation.

Hormone therapy's current FDA approvals cover vasomotor symptoms, genitourinary syndrome, and osteoporosis prevention, leaving mood disturbances without an official indication. Given that an estimated 60% to 86% of menopausal women seek medical care for symptoms, and that low estrogen has been tied to altered brain activity and serotonin imbalance, these results add to a growing evidence base that may eventually inform screening protocols and treatment guidelines.